Advertisement
Corrigendum Free access | 10.1172/JCI89436
Find articles by Cui, L. in: JCI | PubMed | Google Scholar
Find articles by Guan, Y. in: JCI | PubMed | Google Scholar
Find articles by Qu, Z. in: JCI | PubMed | Google Scholar
Find articles by Zhang, J. in: JCI | PubMed | Google Scholar
Find articles by Liao, B. in: JCI | PubMed | Google Scholar
Find articles by Ma, B. in: JCI | PubMed | Google Scholar
Find articles by Qian, J. in: JCI | PubMed | Google Scholar
Find articles by Li, D. in: JCI | PubMed | Google Scholar
Find articles by Li, W. in: JCI | PubMed | Google Scholar
Find articles by Xu, G. in: JCI | PubMed | Google Scholar
Find articles by Jin, Y. in: JCI | PubMed | Google Scholar
Published October 3, 2016 - More info
Tumor formation constitutes a major obstacle to the clinical application of embryonic stem cell–derived (ESC-derived) cells. In an attempt to find major extracellular signaling and intrinsic factors controlling tumorigenicity and therapeutic functionality of transplanted ESC-derived retinal progenitor cells (ESC-RPCs), we evaluated multiple kinds of ESC-RPCs in a mouse retinal degeneration model and conducted genome-wide gene expression profiling. We identified canonical WNT signaling as a critical determinant for the tumorigenicity and therapeutic function of ESC-RPCs. The function of WNT signaling is primarily mediated by TCF7, which directly induces expression of
Lu Cui, Yuan Guan, Zepeng Qu, Jingfa Zhang, Bing Liao, Bo Ma, Jiang Qian, Dangsheng Li, Weiye Li, Guo-Tong Xu, Ying Jin
Original citation: J Clin Invest. 2013;123(4):1647–1661. doi:10.1172/JCI65048.
Citation for this corrigendum: J Clin Invest. 2016;126(10):4061. doi:10.1172/JCI89436.
In Figure 4D, the merged image showing fTCF7, NESTIN, and BrdU staining of Vector-ESC-RPCs and the merged image showing SOX2, PCNA, and BrdU staining of ΔNTcf7-ESC-RPCs were mislabeled. The correctly labeled images are below.
The authors regret the error.